Stockreport

Tango Therapeutics Announces Discontinuation of TNG348 Program [Yahoo! Finance]

Tango Therapeutics, Inc.  (TNGX) 
PDF – Cash runway extended into 2027, PRMT5 and CoREST clinical programs remain on track – BOSTON, May 23, 2024 BUSINESS WIRE )--Tango Therapeutics, Inc. (NASDAQ: TNGX), [Read more]